世界のアクチビンおよびインヒビン市場:成長動向・競争分析2020-2026

【英語タイトル】Global Activin and Inhibin Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP00014)・商品コード:QYR20AP00014
・発行会社(調査会社):QYResearch
・発行日:2020年3月23日(※2024年版があります。お問い合わせください)
・ページ数:116
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、アクチビンおよびインヒビンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、アクチビンおよびインヒビンのグローバル市場動向、メーカー別競争状況、種類別市場規模(アクチビン、インヒビン)、用途別市場規模(商業研究、学術研究)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・アクチビンおよびインヒビンの種類別市場2015-2026:アクチビン、インヒビン
・アクチビンおよびインヒビンの用途別市場2015-2026:商業研究、学術研究
・アクチビンおよびインヒビンの北米市場分析
・アクチビンおよびインヒビンのアジア市場分析
・アクチビンおよびインヒビンの中南米市場分析
・アクチビンおよびインヒビンの中東・アフリカ市場分析
・関連企業情報:Merck Millipore、Thermo Fisher Scientific、Bio-Techne、StemRD、Prospec、Proteintech Group、Ajinomoto、Enzo Life Sciences、IBL、STEMCELL、Sino Biological、PeproTech、ReproCELL
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

In 2019, the global Activin and Inhibin market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Activin and Inhibin.The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Activin and Inhibin market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Activin and Inhibin market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Activin and Inhibin market. Readers of the report can become informed about current and future trends of the global Activin and Inhibin market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Activin and Inhibin markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Activin and Inhibin market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Activin and Inhibin market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Activin and Inhibin market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Activin and Inhibin market is segmented into
Activin
Inhibin

Market Segment by Application, the Activin and Inhibin market is segmented into
Commercial Research
Academic Research

This report includes the following manufacturers; we can also add the other companies as you want.
Merck Millipore
Thermo Fisher Scientific
Bio-Techne
StemRD
Prospec
Proteintech Group
Ajinomoto
Enzo Life Sciences
IBL
STEMCELL
Sino Biological
PeproTech
ReproCELL

The study objectives are:
To analyze and research the global Activin and Inhibin status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Activin and Inhibin manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Activin and Inhibin are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Activin and Inhibin Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Activin and Inhibin Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Activin
1.3.3 Inhibin
1.4 Market Segment by Application
1.4.1 Global Activin and Inhibin Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Commercial Research
1.4.3 Academic Research
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Activin and Inhibin Revenue (2015-2026)
2.1.1 Global Activin and Inhibin Revenue (2015-2026)
2.1.2 Global Activin and Inhibin Sales (2015-2026)
2.2 Activin and Inhibin Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Activin and Inhibin Sales by Regions (2015-2020)
2.2.2 Global Activin and Inhibin Revenue by Regions (2015-2020)
2.3 Global Top Activin and Inhibin Regions (Countries) Ranking by Market Size
2.4 Activin and Inhibin Industry Trends
2.4.1 Activin and Inhibin Market Top Trends
2.4.2 Market Drivers
2.4.3 Activin and Inhibin Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Activin and Inhibin Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Activin and Inhibin Manufacturers by Sales (2015-2020)
3.1.1 Global Activin and Inhibin Sales by Manufacturers (2015-2020)
3.1.2 Global Activin and Inhibin Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Activin and Inhibin Sales in 2019
3.2 Global Top Manufacturers Activin and Inhibin by Revenue
3.2.1 Global Activin and Inhibin Revenue by Manufacturers (2015-2020)
3.2.2 Global Activin and Inhibin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Activin and Inhibin Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Activin and Inhibin as of 2019)
3.4 Global Activin and Inhibin Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Activin and Inhibin Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Activin and Inhibin Market
3.7 Key Manufacturers Activin and Inhibin Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Activin and Inhibin Historic Market Review by Type (2015-2020)
4.1.2 Global Activin and Inhibin Sales Market Share by Type (2015-2020)
4.1.3 Global Activin and Inhibin Revenue Market Share by Type (2015-2020)
4.1.4 Activin and Inhibin Price by Type (2015-2020)
4.1 Global Activin and Inhibin Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Activin and Inhibin Sales Forecast by Type (2021-2026)
4.2.3 Global Activin and Inhibin Revenue Forecast by Type (2021-2026)
4.2.4 Activin and Inhibin Price Forecast by Type (2021-2026)

5 Global Activin and Inhibin Market Size by Application
5.1 Global Activin and Inhibin Historic Market Review by Application (2015-2020)
5.1.2 Global Activin and Inhibin Sales Market Share by Application (2015-2020)
5.1.3 Global Activin and Inhibin Revenue Market Share by Application (2015-2020)
5.1.4 Activin and Inhibin Price by Application (2015-2020)
5.2 Global Activin and Inhibin Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Activin and Inhibin Sales Forecast by Application (2021-2026)
5.2.3 Global Activin and Inhibin Revenue Forecast by Application (2021-2026)
5.2.4 Activin and Inhibin Price Forecast by Application (2021-2026)

6 North America
6.1 North America Activin and Inhibin Breakdown Data by Company
6.2 North America Activin and Inhibin Breakdown Data by Type
6.3 North America Activin and Inhibin Breakdown Data by Application
6.4 North America Activin and Inhibin Breakdown Data by Countries
6.4.1 North America Activin and Inhibin Sales by Countries
6.4.2 North America Activin and Inhibin Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Activin and Inhibin Breakdown Data by Company
7.2 Europe Activin and Inhibin Breakdown Data by Type
7.3 Europe Activin and Inhibin Breakdown Data by Application
7.4 Europe Activin and Inhibin Breakdown Data by Countries
7.4.1 Europe Activin and Inhibin Sales by Countries
7.4.2 Europe Activin and Inhibin Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Activin and Inhibin Breakdown Data by Company
8.2 Asia Pacific Activin and Inhibin Breakdown Data by Type
8.3 Asia Pacific Activin and Inhibin Breakdown Data by Application
8.4 Asia Pacific Activin and Inhibin Breakdown Data by Regions
8.4.1 Asia Pacific Activin and Inhibin Sales by Regions
8.4.2 Asia Pacific Activin and Inhibin Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Activin and Inhibin Breakdown Data by Company
9.2 Latin America Activin and Inhibin Breakdown Data by Type
9.3 Latin America Activin and Inhibin Breakdown Data by Application
9.4 Latin America Activin and Inhibin Breakdown Data by Countries
9.4.1 Latin America Activin and Inhibin Sales by Countries
9.4.2 Latin America Activin and Inhibin Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Activin and Inhibin Breakdown Data by Type
10.2 Middle East and Africa Activin and Inhibin Breakdown Data by Application
10.3 Middle East and Africa Activin and Inhibin Breakdown Data by Countries
10.3.1 Middle East and Africa Activin and Inhibin Sales by Countries
10.3.2 Middle East and Africa Activin and Inhibin Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Merck Millipore
11.1.1 Merck Millipore Corporation Information
11.1.2 Merck Millipore Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Merck Millipore Activin and Inhibin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Merck Millipore Activin and Inhibin Products and Services
11.1.5 Merck Millipore SWOT Analysis
11.1.6 Merck Millipore Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Corporation Information
11.2.2 Thermo Fisher Scientific Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Thermo Fisher Scientific Activin and Inhibin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Thermo Fisher Scientific Activin and Inhibin Products and Services
11.2.5 Thermo Fisher Scientific SWOT Analysis
11.2.6 Thermo Fisher Scientific Recent Developments
11.3 Bio-Techne
11.3.1 Bio-Techne Corporation Information
11.3.2 Bio-Techne Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Bio-Techne Activin and Inhibin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Bio-Techne Activin and Inhibin Products and Services
11.3.5 Bio-Techne SWOT Analysis
11.3.6 Bio-Techne Recent Developments
11.4 StemRD
11.4.1 StemRD Corporation Information
11.4.2 StemRD Business Overview and Total Revenue (2019 VS 2018)
11.4.3 StemRD Activin and Inhibin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 StemRD Activin and Inhibin Products and Services
11.4.5 StemRD SWOT Analysis
11.4.6 StemRD Recent Developments
11.5 Prospec
11.5.1 Prospec Corporation Information
11.5.2 Prospec Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Prospec Activin and Inhibin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Prospec Activin and Inhibin Products and Services
11.5.5 Prospec SWOT Analysis
11.5.6 Prospec Recent Developments
11.6 Proteintech Group
11.6.1 Proteintech Group Corporation Information
11.6.2 Proteintech Group Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Proteintech Group Activin and Inhibin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Proteintech Group Activin and Inhibin Products and Services
11.6.5 Proteintech Group SWOT Analysis
11.6.6 Proteintech Group Recent Developments
11.7 Ajinomoto
11.7.1 Ajinomoto Corporation Information
11.7.2 Ajinomoto Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Ajinomoto Activin and Inhibin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Ajinomoto Activin and Inhibin Products and Services
11.7.5 Ajinomoto SWOT Analysis
11.7.6 Ajinomoto Recent Developments
11.8 Enzo Life Sciences
11.8.1 Enzo Life Sciences Corporation Information
11.8.2 Enzo Life Sciences Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Enzo Life Sciences Activin and Inhibin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Enzo Life Sciences Activin and Inhibin Products and Services
11.8.5 Enzo Life Sciences SWOT Analysis
11.8.6 Enzo Life Sciences Recent Developments
11.9 IBL
11.9.1 IBL Corporation Information
11.9.2 IBL Business Overview and Total Revenue (2019 VS 2018)
11.9.3 IBL Activin and Inhibin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 IBL Activin and Inhibin Products and Services
11.9.5 IBL SWOT Analysis
11.9.6 IBL Recent Developments
11.10 STEMCELL
11.10.1 STEMCELL Corporation Information
11.10.2 STEMCELL Business Overview and Total Revenue (2019 VS 2018)
11.10.3 STEMCELL Activin and Inhibin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 STEMCELL Activin and Inhibin Products and Services
11.10.5 STEMCELL SWOT Analysis
11.10.6 STEMCELL Recent Developments
11.11 Sino Biological
11.11.1 Sino Biological Corporation Information
11.11.2 Sino Biological Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Sino Biological Activin and Inhibin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Sino Biological Activin and Inhibin Products and Services
11.11.5 Sino Biological SWOT Analysis
11.11.6 Sino Biological Recent Developments
11.12 PeproTech
11.12.1 PeproTech Corporation Information
11.12.2 PeproTech Business Overview and Total Revenue (2019 VS 2018)
11.12.3 PeproTech Activin and Inhibin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 PeproTech Activin and Inhibin Products and Services
11.12.5 PeproTech SWOT Analysis
11.12.6 PeproTech Recent Developments
11.13 ReproCELL
11.13.1 ReproCELL Corporation Information
11.13.2 ReproCELL Business Overview and Total Revenue (2019 VS 2018)
11.13.3 ReproCELL Activin and Inhibin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 ReproCELL Activin and Inhibin Products and Services
11.13.5 ReproCELL SWOT Analysis
11.13.6 ReproCELL Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Activin and Inhibin Sales Channels
12.2.2 Activin and Inhibin Distributors
12.3 Activin and Inhibin Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Activin and Inhibin Sales Forecast (2021-2026)
13.1.1 Global Activin and Inhibin Sales Forecast by Regions (2021-2026)
13.1.2 Global Activin and Inhibin Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Activin and Inhibin Sales Forecast (2021-2026)
13.2.2 North America Activin and Inhibin Revenue Forecast (2021-2026)
13.2.3 North America Activin and Inhibin Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Activin and Inhibin Sales Forecast (2021-2026)
13.3.2 Europe Activin and Inhibin Revenue Forecast (2021-2026)
13.3.3 Europe Activin and Inhibin Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Activin and Inhibin Sales Forecast (2021-2026)
13.4.2 Asia Pacific Activin and Inhibin Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Activin and Inhibin Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Activin and Inhibin Sales Forecast (2021-2026)
13.5.2 Latin America Activin and Inhibin Revenue Forecast (2021-2026)
13.5.3 Latin America Activin and Inhibin Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Activin and Inhibin Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Activin and Inhibin Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Activin and Inhibin Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Activin and Inhibin Key Market Segments
Table 2. Ranking of Global Top Activin and Inhibin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Activin and Inhibin Market Size Growth Rate by Type 2021-2026 (K Doses) & (Million US$)
Table 4. Major Manufacturers of Activin
Table 5. Major Manufacturers of Inhibin
Table 6. Global Activin and Inhibin Market Share by Application 2019-2025 (K Doses)
Table 7. Global Activin and Inhibin Market Size by Regions 2015-2020 (K Doses) & (Million US$)
Table 8. Global Activin and Inhibin Sales by Regions 2015-2020 (K Doses)
Table 9. Global Activin and Inhibin Sales Market Share by Regions 2015-2020
Table 10. Global Activin and Inhibin Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Activin and Inhibin Revenue Market Share by Regions 2015-2020
Table 12. Top Activin and Inhibin Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Activin and Inhibin Key Drivers: Impact Analysis (2021-2026)
Table 15. Activin and Inhibin Key Challenges
Table 16. Main Points Interviewed from Key Activin and Inhibin Players: Views for Future
Table 17. Global Activin and Inhibin Sales by Manufacturers (2015-2020) (K Doses)
Table 18. Global Activin and Inhibin Sales Share by Manufacturers (2015-2020)
Table 19. Activin and Inhibin Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Activin and Inhibin Revenue Share by Manufacturers (2015-2020)
Table 21. Global Activin and Inhibin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Activin and Inhibin as of 2019)
Table 23. Key Manufacturers Activin and Inhibin Average Selling Price (ASP) (2015-2020) (USD/Doses)
Table 24. Key Manufacturers Activin and Inhibin Plants/Factories Distribution
Table 25. Key Manufacturers Activin and Inhibin Area Served
Table 26. Date of Key Manufacturers Enter into Activin and Inhibin Market
Table 27. Key Manufacturers Activin and Inhibin Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Activin Sales and Revenue (2015-2020) (K Doses) & (Million US$)
Table 30. Global Inhibin Sales and Revenue (2015-2020) (K Doses) & (Million US$)
Table 31. Global Activin and Inhibin Sales (K Doses) by Type (2015-2020)
Table 32. Global Activin and Inhibin Sales Share by Type (2015-2020)
Table 33. Global Activin and Inhibin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Activin and Inhibin Price (K Doses) by Type (2015-2020)
Table 35. Global Activin and Inhibin Sales (K Doses) by Type (2021-2026)
Table 36. Global Activin and Inhibin Sales Share by Type (2021-2026)
Table 37. Global Activin and Inhibin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Activin and Inhibin Revenue Share by Type (2021-2026)
Table 39. Global Activin and Inhibin Price (K Doses) by Type (2021-2026)
Table 40. Global Activin and Inhibin Sales (K Doses) by Application (2015-2020)
Table 41. Global Activin and Inhibin Sales Share by Application (2015-2020)
Table 42. Global Activin and Inhibin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Activin and Inhibin Price by Application 2015-2020 (USD/Doses)
Table 44. Global Activin and Inhibin Sales by Application (2015-2020) (K Doses)
Table 45. Global Activin and Inhibin Sales Share by Application (2015-2020)
Table 46. Global Activin and Inhibin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Activin and Inhibin Revenue Share by Application (2021-2026)
Table 48. Global Activin and Inhibin Price (K Doses) by Application (2021-2026)
Table 49. North America Activin and Inhibin Sales by Company (2015-2020) (K Doses)
Table 50. North America Activin and Inhibin Sales Market Share by Company (2015-2020)
Table 51. North America Activin and Inhibin Sales by Type (2015-2020) (K Doses)
Table 52. North America Activin and Inhibin Sales Market Share by Type (2015-2020)
Table 53. North America Activin and Inhibin Sales by Application (2015-2020) (K Doses)
Table 54. North America Activin and Inhibin Sales Market Share by Application (2015-2020)
Table 55. North America Activin and Inhibin Sales by Countries (2015-2020) (K Doses)
Table 56. North America Activin and Inhibin Sales Market Share by Countries (2015-2020)
Table 57. North America Activin and Inhibin Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Activin and Inhibin Revenue Market Share by Countries (2015-2020)
Table 59. Europe Activin and Inhibin Sales by Company (2015-2020) (K Doses)
Table 60. Europe Activin and Inhibin Sales Market Share by Company (2015-2020)
Table 61. Europe Activin and Inhibin Sales by Type (2015-2020) (K Doses)
Table 62. Europe Activin and Inhibin Sales Market Share by Type (2015-2020)
Table 63. Europe Activin and Inhibin Sales by Application (2015-2020) (K Doses)
Table 64. Europe Activin and Inhibin Sales Market Share by Application (2015-2020)
Table 65. Europe Activin and Inhibin Sales by Countries (2015-2020) (K Doses)
Table 66. Europe Activin and Inhibin Sales Market Share by Countries (2015-2020)
Table 67. Europe Activin and Inhibin Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Activin and Inhibin Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Activin and Inhibin Sales by Regions (2015-2020) (K Doses)
Table 70. Asia Pacific Activin and Inhibin Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Activin and Inhibin Sales by Type (2015-2020) (K Doses)
Table 72. Asia Pacific Activin and Inhibin Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Activin and Inhibin Sales by Application (2015-2020) (K Doses)
Table 74. Asia Pacific Activin and Inhibin Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Activin and Inhibin Sales by Countries (2015-2020) (K Doses)
Table 76. Asia Pacific Activin and Inhibin Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Activin and Inhibin Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Activin and Inhibin Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Activin and Inhibin Sales by Company (2015-2020) (K Doses)
Table 80. Latin America Activin and Inhibin Sales Market Share by Company (2015-2020)
Table 81. Latin America Activin and Inhibin Sales by Type (2015-2020) (K Doses)
Table 82. Latin America Activin and Inhibin Sales Market Share by Type (2015-2020)
Table 83. Latin America Activin and Inhibin Sales by Application (2015-2020) (K Doses)
Table 84. Latin America Activin and Inhibin Sales Market Share by Application (2015-2020)
Table 85. Latin America Activin and Inhibin Sales by Countries (2015-2020) (K Doses)
Table 86. Latin America Activin and Inhibin Sales Market Share by Countries (2015-2020)
Table 87. Latin America Activin and Inhibin Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Activin and Inhibin Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Activin and Inhibin Sales by Type (2015-2020) (K Doses)
Table 90. Middle East and Africa Activin and Inhibin Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Activin and Inhibin Sales by Application (2015-2020) (K Doses)
Table 92. Middle East and Africa Activin and Inhibin Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Activin and Inhibin Sales by Countries (2015-2020) (K Doses)
Table 94. Middle East and Africa Activin and Inhibin Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Activin and Inhibin Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Activin and Inhibin Revenue Market Share by Countries (2015-2020)
Table 97. Merck Millipore Company Details
Table 98. Merck Millipore Description and Business Overview
Table 99. Merck Millipore Activin and Inhibin Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 100. Merck Millipore Activin and Inhibin Sales Growth Rate (2015-2020)
Table 101. Merck Millipore Activin and Inhibin Sales Market Share in Global Market
Table 102. Merck Millipore Recent Development
Table 103. Thermo Fisher Scientific Company Details
Table 104. Thermo Fisher Scientific Description and Business Overview
Table 105. Thermo Fisher Scientific Activin and Inhibin Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 106. Thermo Fisher Scientific Activin and Inhibin Sales Growth Rate (2015-2020)
Table 107. Thermo Fisher Scientific Activin and Inhibin Sales Market Share in Global Market
Table 108. Thermo Fisher Scientific Recent Development
Table 109. Bio-Techne Company Details
Table 110. Bio-Techne Description and Business Overview
Table 111. Bio-Techne Activin and Inhibin Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 112. Bio-Techne Activin and Inhibin Sales Growth Rate (2015-2020)
Table 113. Bio-Techne Activin and Inhibin Sales Market Share in Global Market
Table 114. Bio-Techne Recent Development
Table 115. StemRD Company Details
Table 116. StemRD Description and Business Overview
Table 117. StemRD Activin and Inhibin Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 118. StemRD Activin and Inhibin Sales Growth Rate (2015-2020)
Table 119. StemRD Activin and Inhibin Sales Market Share in Global Market
Table 120. StemRD Recent Development
Table 121. Prospec Company Details
Table 122. Prospec Description and Business Overview
Table 123. Prospec Activin and Inhibin Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 124. Prospec Activin and Inhibin Sales Growth Rate (2015-2020)
Table 125. Prospec Activin and Inhibin Sales Market Share in Global Market
Table 126. Prospec Recent Development
Table 127. Proteintech Group Company Details
Table 128. Proteintech Group Description and Business Overview
Table 129. Proteintech Group Activin and Inhibin Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 130. Proteintech Group Activin and Inhibin Sales Growth Rate (2015-2020)
Table 131. Proteintech Group Activin and Inhibin Sales Market Share in Global Market
Table 132. Proteintech Group Recent Development
Table 133. Ajinomoto Company Details
Table 134. Ajinomoto Description and Business Overview
Table 135. Ajinomoto Activin and Inhibin Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 136. Ajinomoto Activin and Inhibin Sales Growth Rate (2015-2020)
Table 137. Ajinomoto Activin and Inhibin Sales Market Share in Global Market
Table 138. Ajinomoto Recent Development
Table 139. Enzo Life Sciences Company Details
Table 140. Enzo Life Sciences Description and Business Overview
Table 141. Enzo Life Sciences Activin and Inhibin Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 142. Enzo Life Sciences Activin and Inhibin Sales Growth Rate (2015-2020)
Table 143. Enzo Life Sciences Activin and Inhibin Sales Market Share in Global Market
Table 144. Enzo Life Sciences Recent Development
Table 145. IBL Company Details
Table 146. IBL Description and Business Overview
Table 147. IBL Activin and Inhibin Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 148. IBL Activin and Inhibin Sales Growth Rate (2015-2020)
Table 149. IBL Activin and Inhibin Sales Market Share in Global Market
Table 150. IBL Recent Development
Table 151. STEMCELL Company Details
Table 152. STEMCELL Description and Business Overview
Table 153. STEMCELL Activin and Inhibin Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 154. STEMCELL Activin and Inhibin Sales Growth Rate (2015-2020)
Table 155. STEMCELL Activin and Inhibin Sales Market Share in Global Market
Table 156. STEMCELL Recent Development
Table 157. Sino Biological Company Details
Table 158. Sino Biological Description and Business Overview
Table 159. Sino Biological Activin and Inhibin Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 160. Sino Biological Activin and Inhibin Sales Growth Rate (2015-2020)
Table 161. Sino Biological Activin and Inhibin Sales Market Share in Global Market
Table 162. Sino Biological Recent Development
Table 163. PeproTech Company Details
Table 164. PeproTech Description and Business Overview
Table 165. PeproTech Activin and Inhibin Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 166. PeproTech Activin and Inhibin Sales Growth Rate (2015-2020)
Table 167. PeproTech Activin and Inhibin Sales Market Share in Global Market
Table 168. PeproTech Recent Development
Table 169. ReproCELL Company Details
Table 170. ReproCELL Description and Business Overview
Table 171. ReproCELL Activin and Inhibin Sales (K Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2015-2020)
Table 172. ReproCELL Activin and Inhibin Sales Growth Rate (2015-2020)
Table 173. ReproCELL Activin and Inhibin Sales Market Share in Global Market
Table 174. ReproCELL Recent Development
Table 175. Activin and Inhibin Distributors List
Table 176. Activin and Inhibin Customers List
Table 177. Global Activin and Inhibin Sales Forecast 2021-2026 (K Doses) & (Million US$)
Table 178. Global Activin and Inhibin Sales Forecast by Type 2021-2026 (K Doses)
Table 179. Global Activin and Inhibin Sales Forecast by Application 2021-2026 (K Doses)
Table 180. Global Activin and Inhibin Sales Forecast by Regions 2021-2026 (K Doses)
Table 181. Global Activin and Inhibin Revenue Forecast by Regions 2021-2026 (Million US$)
Table 182. North America Activin and Inhibin Sales Forecast by Countries 2021-2026 (K Doses)
Table 183. North America Activin and Inhibin Revenue Forecast by Countries 2021-2026
Table 184. Europe Activin and Inhibin Sales Forecast by Countries 2021-2026 (K Doses)
Table 185. Europe Activin and Inhibin Revenue Market Share Forecast by Countries 2021-2026
Table 186. Asia Pacific Activin and Inhibin Sales Forecast by Regions 2021-2026 (K Doses)
Table 187. Asia Pacific Activin and Inhibin Revenue Forecast by Regions 2021-2026 (Million US$)
Table 188. Latin America Activin and Inhibin Sales Forecast by Countries 2021-2026 (K Doses)
Table 189. Latin America Activin and Inhibin Revenue Forecast by Countries 2021-2026 (Million US$)
Table 190. Middle East and Africa Activin and Inhibin Sales Forecast by Regions 2021-2026 (K Doses)
Table 191. Middle East and Africa Activin and Inhibin Revenue Forecast by Regions 2021-2026 (Million US$)
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Activin and Inhibin Product Picture
Figure 2. Global Activin and Inhibin Sales Market Shar by Type 2015-2026
Figure 3. Activin Figures
Figure 4. Inhibin Figures
Figure 5. Global Activin and Inhibin Sales Market Share by Application in 2019 & 2026
Figure 6. Commercial Research Use Case
Figure 7. Academic Research Use Case
Figure 8. Activin and Inhibin Report Years Considered
Figure 9. Global Activin and Inhibin Market Size 2015-2026 (Million US$)
Figure 10. Global Activin and Inhibin Sales 2015-2020 (K Doses)
Figure 11. Global Activin and Inhibin Market Size Market Share by Regions 2015-2020
Figure 12. Global Activin and Inhibin Sales Market Share by Regions in 2019
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Activin and Inhibin Sales Share by Manufacturers in 2019
Figure 15. The 5 and 10 Largest Manufacturers in the World: Market Share by Activin and Inhibin Sales in 2019
Figure 16. Activin and Inhibin Value Share by Manufacturers in 2019
Figure 17. Activin and Inhibin Revenue Share by Manufacturers In 2019
Figure 18. Activin and Inhibin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Activin and Inhibin Revenue Share by Type (2015-2020)
Figure 20. Global Activin and Inhibin Revenue Growth Rate by Type in 2015 & 2019
Figure 21. Global Activin and Inhibin Market Share by Price Range (2015-2020)
Figure 22. Global Activin and Inhibin Revenue Share by Application (2015-2020)
Figure 23. Global Activin and Inhibin Revenue Growth Rate by Application in 2015 & 2019
Figure 24. North America Activin and Inhibin Revenue Growth Rate 2015-2020 (Million US$)
Figure 25. U.S. Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 26. Canada Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 27. Europe Activin and Inhibin Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. Germany Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 29. France Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 30. U.K. Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 31. Italy Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 32. Russia Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 33. Asia Pacific Activin and Inhibin Revenue Growth Rate 2015-2020 (Million US$)
Figure 34. China Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 35. Japan Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 36. South Korea Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 37. India Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 38. Australia Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 39. Taiwan Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 40. Indonesia Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 41. Thailand Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 42. Malaysia Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 43. Philippines Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 44. Vietnam Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 45. Latin America Activin and Inhibin Revenue Growth Rate 2015-2020 (Million US$)
Figure 46. Mexico Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 47. Brazil Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 48. Argentina Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Middle East and Africa Activin and Inhibin Revenue Growth Rate 2015-2020 (Million US$)
Figure 50. Turkey Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Saudi Arabia Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 52. U.A.E Activin and Inhibin Sales Growth Rate (2015-2020) (K Doses)
Figure 53. Merck Millipore Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Bio-Techne Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. StemRD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Prospec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Proteintech Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Ajinomoto Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Enzo Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. IBL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. STEMCELL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Sino Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. PeproTech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. ReproCELL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Activin and Inhibin Value Chain
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 69. North America Activin and Inhibin Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 70. North America Activin and Inhibin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 71. Europe Activin and Inhibin Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 72. Europe Activin and Inhibin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 73. Asia Pacific Activin and Inhibin Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 74. Asia Pacific Activin and Inhibin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 75. Latin America Activin and Inhibin Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 76. Latin America Activin and Inhibin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 77. Middle East and Africa Activin and Inhibin Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 78. Middle East and Africa Activin and Inhibin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed


【掲載企業】

Merck Millipore、Thermo Fisher Scientific、Bio-Techne、StemRD、Prospec、Proteintech Group、Ajinomoto、Enzo Life Sciences、IBL、STEMCELL、Sino Biological、PeproTech、ReproCELL

★調査レポート[世界のアクチビンおよびインヒビン市場:成長動向・競争分析2020-2026] (コード:QYR20AP00014)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアクチビンおよびインヒビン市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆